Clinical trial of antivirals for COVID-19 infection
PANORAMIC |
---|
|
Study type | platform trial |
---|
Dates | Dec 2021 - ongoing |
---|
Locations | United Kingdom |
---|
Lead researcher | Chris Butler, Paul Little |
---|
Funding | National Institute for Health and Care Research (NIHR) |
---|
The PANORAMIC trial (short for Platform Adaptive Trial of Novel Antivirals for Early Treatment of COVID-19 in the Community) is a clinical trial in the United Kingdom testing the effectiveness of new antiviral drugs at the early stages of COVID-19 infections.[1][2][3] The study aims to find out if antivirals can prevent death and hospitalisation and help faster recovery for people aged over 50 and those at higher risk due to underlying health conditions.[4] The trial was launched in December 2021,[5] and had nearly 30,000 people enrolled as participants.[6]